Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_540_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
86 Мб
Скачать
Anesthetic andPerioperative
https://t.me/medicina_free
Management
2
Abstract
To provide safe anesthesia for mother and fetus following goals should be reached: (1) optimization and maintenance of normal maternal physiological function, (2) optimi­zation and maintenance of uteroplacental blood ow and oxygen delivery, (3) avoid­ance of unwanted drug effects on the fetus, (4) avoidance of stimulating the myometrium (oxytocic effects), (5) avoidance of maternal awareness during general anesthesia, and (6) use of regional anesthesia, if possible. Sugammadex rapidly reverses neuromuscu­lar blockade without fetal harm. Antibiotics and thromboprophylaxis are the most com­mon medications administered for acute abdomen during pregnancy. Antibiotics should be administered according to the FDA drug classes. Anesthetic management is chal­lenging in patients with abdominal trauma or polytrauma when in addition to hemorrhagic shock, there are problems with the patient’s airway management. Preoperative and post­operative fetal monitoring is essential for early recognition of fetal distress, inuenc­ing the timing and type of combined obstetric and surgical intervention.
2.1 Anesthetic Management
Before discussing anesthesiologic issues related to the acute abdomen during pregnancy, it is important to stress that a delay in indicating and performing necessary surgery leads to worse maternal and fetal outcomes.
A pregnant woman should never be denied medically necessary surgery or have that sur­gery delayed regardless of trimester because this can adversely affect the pregnant woman and her fetus. (ACOG 2019 [1])
To provide safe anesthesia for the mother and
fetus, following goals should be reached:
• optimization and maintenance of normal
maternal physiological function,
• optimization and maintenance of uteroplacen-
tal blood ow and oxygen delivery,
• avoidance of unwanted drug effects on the
fetus,
• avoidance of stimulating the myometrium
(oxytocic effects),
• avoidance of maternal awareness during gen-
eral anesthesia,
• use of regional anesthesia, if possible.
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 G. Augustin, Acute Abdomen During Pregnancy, https://doi.org/10.1007/978-3-031-26021-6_2
17
18
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
2.1.1 Anesthetic Medications
2.1.1.1 General Anesthesia
Anesthetic concerns in the pregnant patient include two major categories: teratogenicity of the anesthetic agents and maternal physiological changes resulting fromanesthetic agents. Therefore, strategies to minimize maternal and fetal exposure to anesthetics are essential (Table2.1).
The teratogenicity of anesthetic agents, resulting in fetal chromosomal damage or carci­nogenesis, is minimal. Any morbidity to the fetus is considered primarily from the underly­ing disease, not the anesthetic agent [2, 3]. There is no increased rate of congenital anoma­lies with different types of anesthesia used in surgery during pregnancy [4, 5]. In a consensus statement published in the New England Journal of Medicine in 2000, no anesthetic agents were listed as denitively causative of fetal malfor­mations [6]. Although without clinical terato­genic outcomes, thetheoretical risk should not
be completely disregarded. Many agree that sur­gery during the rst trimester, the period of organogenesis, should be avoided if not emer­gent [3, 7, 8]. Table2.2 shows the list of com­mon anesthetic drugs and their classication per FDA category.
Several points should be stressed when con­sidering the possible teratogenicity of various anesthetic agents. First, the background inci­dence of congenital anomalies in humans is approximately 3%. Second, physiologic derange­ments such as hypoxemia, hypercarbia, stress, and hypotension may be teratogenic. These prob­lems can occur during anesthesia and surgery and sometimes exist preoperatively [10].
No currently used anesthetic agents have
been shown to have any teratogenic effects
in humans when using standard concentra-
tions at any gestational age. (ACOG 2019
[1])
Table 2.1 Strategies to minimize patient exposure to and dose and duration of anesthetics
Type of surgery Anesthetic technique Suggested modication/recommendation Obstetric Neuraxial (epidural or spinal) utilizing
local anesthetics±opioids
Non-obstetric (non-emergent) Neuraxial as above (if applicable) or None
General anesthesia utilizing inhalational agents
Non-obstetric (emergent) General anesthesia utilizing inhalational
agents
Fetal procedures Local anesthesia No change
Neuraxial anesthesia No change IV sedative—hypnotic—propofol <3h duration—no change
IV sedative—Midazolam Consider IV opioids (fentanyl or
General anesthesia with inhalational agents
General anesthesia with increased concentration of inhalational agents for uterine relaxation
Reproduced with permission from [9] IV intravenous
a
Atosiban is not approved for use in the USA by the FDA
b
Nitroglycerin is difcult to titrate to effect, may result in intractable hypotension and/or pulmonary edema
None
<3h duration—No change >3h durations—consider deferring until postpartum Limit times: (a) Between induction and start of
surgery and
(b) Between end of surgery and end
of anesthesia
>3h duration—discuss risk/benet
remifentanil) or IV dexmedetomidine <3h duration—no change >3h duration—discuss risk/benet Consider supplementing with magnesium sulfate, Atosibana or Nitroglycerinb for intraoperative tocolysis
2.1 Anesthetic Management
https://t.me/medicina_free
Table 2.2 The placental transfer characteristics of commonly used anesthetic drugs
Placental
Drug Properties Induction agents Thiopental Highly lipid soluble, weak
acid
Propofol Lipid soluble +++ Transient depression of Apgar score and
Ketamine Weak base ++++ F/M ratio 1.26 occurs within 2min of
Inhalation agents Volatile anesthetics Highly lipid soluble; low
molecular weight Nitrous oxide ++ Possible diffusion hypoxia in neonate Opioids Morphine Less lipid soluble; but low
protein-binding Fentanyl Lipid soluble +++ Pethidine Only 50% plasma protein
bound
Remifentanil + No adverse fetal effects as rapidly
Naloxone +++ Though short-term safety of naloxone is
Benzodiazepine Highly lipid soluble ++ More neonatal depression, midazolam—
NM blockers Large molecules; poorly lipid
soluble; highly ionized Anticholinergics Atropine Lipid soluble; tertiary amine ++ Glycopyrrolate Fully ionized; quaternary
ammonium compound Neostigmine Quaternary ammonium
compound; but a small
molecule Local anesthetics Lignocaine Less lipid soluble; low
protein binding Bupivacaine; ropivacaine
Reproduced with permission from [10] under the CC BY 3.0 F/M fetal/maternal, NM neuromuscular
Highly lipid soluble; but high
protein binding
transfer Remarks
+++ Quickly cleared by neonate after delivery
neurobehavioral effects in neonate
intravenous bolus
+++ Greater sedative effect on neonate if
dose-delivery interval is prolonged
++
++ Prolonged neonatal depression due to
increased half-life of meperidine and its metabolite—normeperidine
metabolized by fetus
well documented, it should be used only in cases of absolute or relative maternal opioid overdose
less placental transfer than diazepam
No signicant clinical effects on fetus
+++ May cause fetal bradycardia; hence it is
better to add atropine to neostigmine in incidental surgery during pregnancy
++ Can accumulate in the fetus due to “ion
trapping” if the fetus becomes acidotic
++
19
The drugs crossing the placenta may be catego­rized into three types. In type 1 (e.g., thiopental), the complete transfer occurs with equilibrating maternal and fetal blood concentrations. In type 2 (e.g., ketamine), the drug reaches a higher concen­tration in fetal blood than maternal blood. Only a minimal amount reaches the fetal blood in type 3 (e.g., succinylcholine).
Sugammadex encapsulates rocuronium and vecuronium molecules, aminosteroid agents
commonly used in general anesthesia [11]. The combination of rocuronium and sugammadex for rapid-sequence induction combines rapid onset and rapid reversal of neuromuscular blockades with avoidance of severe side effects. It is a very comfortable combination during Cesarean sec­tion (CS) [12]. Although the impact of pregnancy on the volume of distribution of sugammadex is unknown, the effectiveness of rocuronium block reversal following 2 or 4mg/kg sugammadex has
20
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
been conrmed [13]. Rapid neuromuscular blockade reversal is conrmed in myasthenia gravis patients during CS [14].
There is concern about sugammadex’s ability to encapsulate progesterone and reduce proges­terone levels. Interaction with hormonal contra­ceptives raises the question of the adverse effects of sugammadex administration on the mainte­nance of the rst trimester of pregnancy. A study on rats in the rst trimester of pregnancy did not
babies are healthy, without congenital abnormali­ties [16]. Sugammadex’s effects on female repro­ductive function, pregnancy, and puerperium are presented in Table2.3.
Magnesium sulfate is used to prevent uterine contractions and preterm labor (see Sect. 4.6.2.1), enhancing the effect of rocuronium. It does not signicantly affect the efcacy of sugammad­exin, reversing rocuronium-induced neuromus­cular blockade [18].
show adverse effects. They did not affect the suc­cessful completion of pregnancy without still­birth or miscarriage [15]. In a case series of pregnant patients undergoing non-obstetric sur­gery, all fetuses showed good vitality in the car­diotocogram performed after the procedure. All
Table 2.3 Effects of Sugammadex on female reproductive function, pregnancy, delivery, and lactation [17]
Context Current evidence Research gaps Women of reproductive
potential
Maintenance of early pregnancy
Maternal–fetal placental transfer
Fetal effects Primary cell cultures: Sugammadex alone in
Cesarean delivery Sugammadex reversal of rocuronium is reported
Lactating women Single preclinical study (unpublished)
In vitro studies (unpublished) indicate that sugammadex binds progesterone, theoretically reducing hormone levels to an extent that is equivalent to missing dose(s) of hormonal contraception (oral, IUD, injectable). This has prompted manufacturer to recommend barrier contraception for 1week following sugammadex exposure Single preclinical study: high-dose sugammadex (30mg/kg) administered to rst trimester pregnant rats failed to reduce endogenous progesterone levels or alter live birth or stillbirth rates Large molecular mass and polarization in aqueous solution predict limited placental transfer
clinically relevant concentrations has been reported to promote neuronal apoptosis in primary cultures, possibly due to oxidative stress from depletion of neuronal cholesterol Mice: No neuronal apoptosis (healthy, mature blood–brain barrier is impermeable to sugammadex). Sugammadex combined with sevourane, which disrupts blood–barrier integrity, results in greater degree of neuronal apoptosis than sevourane alone
to be safe and effective in parturients at the end of CD surgery. This includes patients with profound NMB (1 posttetanic twitch) reversed with 4mg/kg (actual body weight)
demonstrated peak sugammadex milk levels 30min after maternal administration in postnatal rats without detectable adverse effects on offspring
2.1.1.2 Sedation andSpinal Anesthesia
Sedation in pregnancy has always been a challenge to anesthetists. During ERCP in pregnant patients, sedation could have side effects from the maternal prone position. Therefore, fetal and maternal moni-
Actual clinical risk of unintended pregnancy due to contraceptive failure after sexual intercourse without barrier contraception following sugammadex exposure is unknown
No human evidence
No evidence regarding placental transfer
Limited preclinical evidence. No human evidence
Effectiveness of sugammadex rescue reversal in cannot intubate/cannot ventilate after 1–1.2mg/kg rocuronium (rapid sequence induction) has not been established or reported No evidence exists regarding the presence of sugammadex in human breast milk
2.1 Anesthetic Management
https://t.me/medicina_free
21
toring is mandatory [19, 20]. Following electrocar­diography, noninvasive blood pressure measurement, pulse oximetry, and fetal heart rate monitoring (FHR) devices are applied. Insufation of oxygen at a ow rate of 6L/min is maintained throughout the procedure. The patients are placed in a left lateral to a prone position. Fetal shielding is accomplished with a lead apron placed between the radiation source and the patient. Although there is no proof of human teratogenicity for anesthetic drugs, inhaled or local, all agents administered dur­ing pregnancy must be used with caution and vigi­lance. Currently, the best options are propofol, midazolam, and fentanyl. Propofol is preferred as a short-acting agent because it can be titrated easily and has a good recovery, with a low incidence of nausea and vomiting. Alternatively, midazolam can be used because of its specic amnesic and anxio­lytic properties. The analgesic component of this sedation regimen is opioids. All drugs are given in incremental doses to prevent hemodynamic and respiratory changes in the mother and fetus during the procedure. The most commonly conscious seda­tion is achieved and maintained with intravenous midazolam 3–5 mg and duodenal hypomotility induced by hyoscine-N-butylbromide 20mg [21].
In utero human exposure to anesthetic or sedative drugs has no effect on the develop­ing brain, and no animal data support an effect with exposures less than 3h. (ACOG
Committee opinion 2019 [1])
Spinal anesthesia is widely used for CS.Although safe, nausea, vomiting, and hypo­tension are frequent after spinal anesthesia despite prehydration and left uterus displace­ment [22]. This is attributed to the greater aorto­caval compression and greater cephalad spread of sensory blockade by an enlarged uterus. MRI shows a gestation-related reduction in cerebro­spinal uid volume and dural sac surface area associated with the engorged veins in the epi­dural space [23]. The question is whether spinal anesthesia is effective in conditions with increased intra- abdominal pressure (IAP).
Whether spinal local anesthetic spread in preg­nant patients shows the association between pre-incision IAP and maximum sensory block levels is unclear [24, 25].
With an inguinal hernia, severe postoperative complications are lower under local anesthesia, including fewer postoperative analgesic require­ments and fewer micturition problems [26]. Operating under general anesthesia in emergency settings is better due to possible unexpected intraoperative ndings.
2.1.2 Airway Management
Airway management becomes particularly prob­lematic due to the physiologic changes during pregnancy. Increased oxygen consumption and mechanical displacement of the abdominal organs cause the pregnant patient to increase minute ventilation, primarily through a 30–40% increase in tidal volume [27]. A compensatory respiratory alkalosis with a PaCO2 from 30 to 35 mmHg develops. End-tidal CO2 monitoring should be used intraoperatively.
The success of regional anesthesia in this pop­ulation owes its popularity mainly to the airway complications that general anesthesia entails. Airway complications are more prevalent in a parturient receiving general anesthesia than those having regional techniques [28]. Unique issues­for the gravid patient in airway management are:
• increased risk of aspiration due to delayed
gastric emptying and decreased lower esopha-
geal sphincter tone in combination with
increased intra-abdominal pressure,
• despite the safety of rapid-sequence intuba-
tion in pregnancy, because of lower serum
pseudocholinesterase levels in pregnancy,
using a lower dose of succinylcholine during
induction is recommended,
• both depolarizing and nondepolarizing muscle
relaxants cross the placenta. Effects of these
drugs on CTG pattern and fetal activity might
lead to a falsely non-reassuring tracing and
non-indicated intervention.
22
https://t.me/medicina_free
A nasogastric tube inserted in a semicon­scious or unconscious, injured pregnant woman prevents aspiration of gastric con­tents [29].
Additionally, vascular engorgement of the respiratory tract during pregnancy may lead to tracheal intubation difculties. Edema in the air­ways leads to friable tissues, increased potential for bleeding, and the necessity to use smaller­sized endotracheal tubes in the parturient [30]. Because decreased lower esophageal sphincter pressure and delayed gastric emptying in preg­nancy can cause an increased risk of aspiration, cricoid pressure prevents aspiration during intu­bation [31]. Therefore, rapid-sequence intubation is preferred for the parturient facing an emergent abdominal operation with a full stomach [30]. Also, the underlying cause of acute abdomen,
Fig. 2.1 Left lateral tilt relieves pressure on inferior vena cava in pregnant women
intraoperative strategy, and possible intraopera­tive complications mandates general anesthesia.
Other compounding airway issues include weight gain, increased breast size, decreased func­tional residual capacity, increased oxygen con­sumption, and the potential for aortal and venocaval compression in the supine position during intuba­tion. These issues may lead to rapid desaturation, potentially lower cardiac output, placental-fetal compromise, and asphyxia during delayed attempts
2.1.2.1 Diaphragmatic Hernia
The affected side is placed uppermost if a herni­ais approached through a thoracotomy [32]. Mediastinal shift, which compromises venous return and collapse of the lower lung, may be worsened by positional compression from the herniated dilated viscera. A rapid-sequence induction is indicated because the patient is at
risk of pulmonary aspiration. at securing the parturient’s airway. In addition to these physiologic changes, disease-induced hypo­tension should be treated initially with aggressive intravenous uid resuscitation. If possible, the patient should be placed in the left lateral decubitus positionto decompress the inferior vena cava to increase venous return (Fig. 2.1). Trendelenburg positioning can also increase the venous return in the hypotensive patient [2].
General endotracheal anesthesia is preferred for CS to manage acute abdomen and early post­operative period. General anesthesia allows greater hemodynamic control and facilitates management of the acid-base status, especially in patients receiving epoprostenol for CVVH in acute pancreatitis during pregnancy. Anticoagulation is better titrated, including hepa­rin in sepsis. Postoperative ventilatory support in ICU permits the resolution of acidosis.
lation may be advantageous with atraumatic dia­phragmatic hernia to expand the atelectatic lung, increase functional residual capacity, and deliver high oxygen concentrations. Lung ventilation must be undertaken with low tidal volume or low airway pressure until the abdominal contents have been removed from the chest or until a thoracot­omy has been performed. Cardiovascular collapse might occur during positive-pressure ventilation. The re-expanded lung previously compressed by herniated viscera may shift mediastinal structures, and venous return may be impeded [33, 34]. Increased pleural pressure from mechanical venti­lation is transmitted to the abdomen. It results in an increased upward displacement of the viscera toward the diaphragm and may worsen cardiovas­cular collapse [34]. A surgeon must be ready to operate before ventilation is begun [33].
2 Anesthetic andPerioperative Management
General anesthesia and positive-pressure venti-
2.1 Anesthetic Management
https://t.me/medicina_free
23
Premedication with an H2 antagonist, metoclo­pramide, and sodium citrate is usual. Rapid- sequence induction with fentanyl, thiopentone, and suxame­thonium is followed by inserting a right-sided endo­bronchial tube. Anesthesia is maintained with enurane in oxygen and nitrous oxide and neuro­muscular blockade with pancuronium [35]. On the other hand, delaying a decision to insert a double­lumen tube may have advantages. First, it may not be necessary if a simple laparotomy sufces; placing double- lumen tubes is often difcult, especially dur­ing rapid-sequence induction. Second, changing tubes intraoperatively allows surgical manipulation of the stomach directly, combined with a nasogastric tube, to ensure the abdominal stomach is empty before a double-lumen tube placement. Head-up tilt also reduces the risk of regurgitation from the abdominal or thoracic stomach [35].
Normal changes of pregnancy include increased cardiac output,which reaches its high­est value after delivery due to blood transfer from the uterus into the systemic circulation and vena­caval compression release [36]. Diaphragmatic hernia is associated with intrathoracic pressure augmentation. It reduces venous return, increases right and left ventricular afterload, and decreases cardiac output. Thus, perioperative hemody­namic monitoring of patients with diaphragmatic hernia could improve uid management. Although a pulmonary artery catheter is an invasive procedure, it is a gold standard for mea­suring cardiac output and pressures directly [37].
2.1.2.2 Abdominal Trauma
The literature on pregnant trauma victims’ obstet­ric, anesthetic, and surgical management is lim­ited [38]. Pregnant trauma victims present a unique spectrum of challenges to the trauma healthcare team. The diagnosis may be unknown at exploration, as may be the nature and extent of the further procedures. Pregnancy may not always be known to the healthcare team (at the scene of transportation accidents, emergency room, or operating room), complicating the situation.
Pregnancy must always be suspected (until
proven otherwise) in female trauma
patients of childbearing age [38].
Vasopressors, rarely indicated in trauma patients, should be avoided unless necessary because of the risk of decreasing uterine blood ow.
If vasopressors are required, ephedrine
should be the rst choice. It preserves the
uterine blood ow, but there should be no
hesitation in using other vasopressors when
necessary.
Head andNeck Injury
Women in late pregnancy have difcult airways. Mallampati class 4 airway (with only the hard palate visible and with no view of the soft palate or uvula) increased by 34% between 12 and 38 weeks [39]. The additional fact that these patients have sustained trauma and will likely be in cervical collars compounds is an already dif­cult situation [40]. If there is uncertainty about the integrity of the cervical spine, direct laryn­goscopy should be avoided, and beroptic (awake beroptic) intubation of the trachea, if feasible (time constraints or equipment availability), should be considered [41]. If direct laryngoscopy is deemed necessary, an “inline stabilization” of the head and neck by an assistant to prevent extension and rotation of the cervical spine is indicated. If awake, beroptic tracheal intubation is chosen. Analgesic and sedative drug titration maintains continual meaningful verbal commu­nication between the anesthesiologist and the patient.
Respiratory depression and aspiration of stom­ach contents with local anesthesia are less likely if the patient remains awake and alert. Also, a ratio­nal, alert mother minimizes the risk of neonatal depression. In patients in anesthesia, nasogastric decompression after intubation reduces the risk of aspiration. Midazolam is the recommended ben­zodiazepine. However, it is highly unionized and lipophilic, and the feto- maternal ratio is 0.76 at 15–20 min after maternal administration. However, unlike other benzodiazepines, the ratio falls rapidly. No adverse fetal effects have been reported [42]. Trauma victims with a GCS ≤8
24
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
usually require intubation and mechanical venti­lation for intracranial pressure and airway control. However, trauma victims with “good” GCS can “talk and deteriorate/die” following a traumatic head injury, particularly an injury associated with loss of consciousness. Delayed deterioration occurs within 48h from the initial insult.
The succinylcholine-induced ICP increase has been a concern in the past. With an urgent need to secure an airway in a head-injured preg­nant trauma victim, succinylcholine is an appro­priate and safe drug. All the intravenous anesthetic agents (except ketamine) cause some degree of vasoconstriction and therefore decrease cerebral blood ow. The inhaled agents have some cerebral vasodilatory effect; however, their administration is usually consistent with accept­able ICP levels [43].
Spinal Cord Injury
The anesthetic management of a spinal cord injury in pregnancy depends upon the lesion’s site, extent, and duration. Complete cord transection is usually associated with cardiovascular instability due to neurogenic shock in the acute phase or subsequent autonomic hyperreexia. In the latter case, epi­dural analgesia blocks afferent pathways, reducing the stimuli and causing paroxysmal sympathetic activity. Parasympathetic pathways are intact, and life-threatening bradycardia can occur. Intravascular volume status can be difcult to assess and manage, particularly in acute injury. Intravenous uid therapy is best guided by central venous pressure monitoring. Attention to the patient’s position and the compression of pelvic venous structures by the gravid uterus distinguish between postural hypotension and volume deple­tion. Maternal hypotension must be avoided to maintain uterine blood ow and avoid secondary ischemic damage in the evolving cord lesion. Irrespective of the chosen method of anesthesia, preoperative and postoperative neurological nd­ings should be documented.
If radiological evidence suggests that the neurological decit is caused by edema, the principal anesthetic concern was to avoid sec­ondary (irreversible) cord damage in the mother and enable timely delivery in case of
acute fetal compromise. If the patient has a normal airway and, other than the cervical col­lar, there are no reasons for anticipating dif­culties with intubation, general anesthesia with inline neck stabilization during intubation is the most appropriate [44].
2.1.2.3 Increased Intra-Abdominal Pressure
Increased IAP(see Chap. 3) is transmitted to the thoracic cage (on average50%), which dimin­ishes lung compliance, decreases functional residual capacity, and increases ventilation/per­fusion mismatch [45]. In critically ill pregnant women, abdominal compartment syndrome man­ifests in several ways. Ventilation becomes increasingly difcult, resulting in increased peak and plateau alveolar pressures, hypercapnia, hypoxia, and increased risk of ventilator­associated lung injury because of the high pres­sures needed to drive ventilation [46].
2.1.2.4 Acute Appendicitis
Pregnant patients with AA, compared to non­pregnant, have similar occurrences of all specic complications except pneumonia, which occurred more frequently in pregnant women (0.7% vs.
0.2%, p = 0.004). All cases of postoperative
pneumonia were observed in women who under­went general endotracheal anesthesia [47].
2.1.2.5 Uterine Rupture
With a UR diagnosis, the mother’s immediate stabilization and delivery of the fetus are impera­tive. After securing the airway and adequate oxy­gen delivery, careful and immediate correction of hypovolemia is mandatory. Patients should have multiple, preferably large-bore, intravenous cath­eters with vigorous uid resuscitation. With com­plete and extensive UR with fetal extrusion into the peritoneal cavity and vaginal bleeding, ergo­metrine may be administered to control bleeding from the rent and the placental site during prepa­ration for laparotomy.
The use of prophylactic antibiotics is contro­versial. Some state that they have no value [48], while others recommend their use [49] because 23% had intraperitoneal sepsis at the time of
2.1 Anesthetic Management
https://t.me/medicina_free
25
laparotomy [50]. Partly it depends on the quan­tity of blood loss. Hypovolemic shock may lead to the translocation of gram-negative bacteria from the ischemic bowel to the bloodstream, complicating the presentation with endotox­emia and septic shock [51]. Hemorrhagic shock increases the incidence of wound infections. Most survived mothers had a mean blood loss of >2000mL [5254]. Blood loss depends on the trimester of UR and uterotonics or prosta­glandins for labor induction. These medications can decrease the amount of blood loss [55].
At least 1000mL of packed red blood cells or blood transfusions should be available [53, 54, 56].
2.1.3 Intraoperative CO2 Monitoring
During laparoscopy, intraoperative CO2 monitor­ing by capnography should be used in the pregnant patient
(Level III).
Fetal acidosis with insufation has not been documented in the human fetus, but concerns over the potentially detrimental effects of acido­sis have led to the recommendation of maternal CO2 monitoring [57, 58]. Initially, there was a debate over maternal blood gas monitoring of arterial carbon dioxide (PaCO2) versus end-tidal carbon dioxide (ETCO2) monitoring. However, the less invasive capnography adequately reects maternal acid-base status in humans [59]. The safety and efcacy of ETCO2 measurements in pregnant women [6062]make routine blood gas monitoring unnecessary.
2.1.4 Extracorporeal Membranous
Oxygenation
2.1.4.1 Considerations inPregnancy
Extracorporeal membranous oxygenation (ECMO) is the last resuscitation treatment for patients with refractory shock. It is a complex
technique for providing life support in severe but potentially reversible respiratory failure. The technique oxygenates the blood outside the body, obviating the need for gas exchange in the lungs and, if necessary, provides cardiovascular support. General indications for ECMO are:
• Severe acute respiratory failure with an expected mortality rate of 80% based on phys­iological variables,
• Reversible respiratory failure,
• Spontaneous circulation not returning because of cardiac arrest or refractory ventricular brillation after 10min CPR,
• Systolic blood pressure cannot be maintained at >70mmHg and inotropic score (IS) >60μg/ kg/min, and intra-aortic balloon pump support (IS, μg/kg/min = dopamine + dobutamine +15 × milrinone +100 × epinephrine +100 × norepinephrine +100×isoprotenolol).
ECMO therapy may be benecial during preg-
nancy or early puerperium in H1N1-related hypoxemia [63, 64], ARDS from various causes [65], and peripartum cardiomyopathy [66]. Venovenous ECMO is indicated for hypoxemic respiratory failure, hypercarbic respiratory fail­ure, respiratory failure in lung transplant, bron­chopleural stulas, pulmonary air leaks, or complex airway management. In venovenous ECMO, no cardiac support is provided, as opposed to venoarterial extracorporeal mem­brane oxygenation [65].
2.1.4.2 Amniotic Fluid Embolism
See Sect. 25.3.6.6. A total of 20 ECMO cases of amniotic uid embolism from 1986 to 2019 were published [67]. Extracorporeal therapies consisted of venoarterial ECMO (11 cases), venovenous ECMO (3 cases), and cardiopulmonary bypass (3 cases, including 2 older cases). Extracorporeal therapies were started after delivery and were con­tinued for a median of 48h. The length of ICU stay ranged from 7 to 59days. Maternal and neonatal survival was 85%. Maternal hemorrhage compli­cated 69% of cases, with a few patients requiring more than 10 red blood cell transfusions [67].
26
https://t.me/medicina_free
2 Anesthetic andPerioperative Management
Although not strongly recommended, from 2020, ECMO for amniotic uid embolism is included in the treatment guidelines— “persistent hemody­namic instability despite medical management or need for prolonged CPR may require consider­ation for VA ECMO” [68]. Postpartum hemor­rhage or DIC should not be considered absolute contraindication [67].
2.1.4.3 Maternal Trauma
A single case of successful ECMO therapy for maternal chest trauma has been reported [69].
2.2 Perioperative Medications
Interests of both the mother and the fetus must be considered in therapy during pregnancy. Usually, these interests do not conict because what is good for the mother is generally good for the fetus. Sometimes maternal therapy must be mod­ied to substitute alternative but safer therapy because of the concerns about drug teratogenicity (e.g., replacing a H2 receptor antagonist for miso­prostol, an abortifacient that is contraindicated during pregnancy) [70, 71]. Rarely, the maternal and fetal interests are opposed, as in chemother­apy for maternal cancer. This therapy is poten­tially life-saving to the mother but life-threatening to the fetus [72]. These conicts raise signicant medical, legal, and ethical issues.
There are many categories of drugs that could have deleterious effects on a fetus, and detailed elaboration is out of the scope of this book. There are three main categories of medications used in these patients: (1) anesthetic medications (see Sect. 2.1.1), (2) prophylactic, and (3) therapeutic. All teratogenic drugs generally determine a spe­cic pattern or single malformation during a sensi­tive gestation period with a dose-dependent effect.
2.2.1 Antibiotics
The US Food and Drug Administration has cate­gorized all antibiotics according to the risks asso­ciated with their use in pregnancy. Two categories are important:
• category A: studies in pregnant women do not demonstrate any risks to the mother or fetus,
• category B: while animal studies show no risk, human studies are inadequate,or animal toxic­ity has been noted, but the studies on humans show no risk.
There are no antibiotics in category A.FDA
Class B antibiotics should be administered when the acute abdomen is highly suspected or found (at least 30–60 min before skin incision) in all patients (administered to 94% of patients in the literature) [73].
2.2.1.1 Acute Appendicitis
Recommended antibiotics are second-genera­tion cephalosporins (FDA Class B), comprising 60% of all antibiotic classes used during preg­nancy for acute appendicitis (AA) [74]. Cephalosporins and metronidazole are indicated for gangrenous or perforated AA [75]. Metronidazole use in pregnant patients is still controversial, with a recommendation against its use during the rst trimester of pregnancy. However, there is no increase in teratogenic risk when used in recommended doses regardless of the trimester [76, 77]. The duration of antibiotic therapy should be discontinued as early as pos­sible. A single preoperative dose is adequate with normal appendix or phlegmonous AA [78]. Even operation without antibiotic therapy for phlegmonous AA is sufcient in the nonpreg­nant population. Therefore, for apregnant patient with high suspicion of AA, the time from admission to the operation should be short as possible.
2.2.1.2 Acute Cholecystitis
Penicillins and second-generation cephalospo­rins are most commonly used. The rst-line treat­ments are ampicillin and sulbactam or cefoxitin/ cefuroxime. There is no consensus on the dura­tion of antibiotic use in pregnancy. Recommendations from the general population can be applied: (1) to use antibiotics until the patient becomes afebrile and without leukocyto­sis or elevated CRP, or (2) single dose or 24-h therapy in organ occupying infection [78].